With the same focus, #SpecializedDiagnostics, Werfen and Omixon are the perfect match. The Omixon team is excited to join Werfen and contribute to #PoweringPatientCare.
Want to meet us? Let's meet and have some fun! Omixon hugely enjoy the social aspects of conferences. Say hello at our booth, share a wine or beer at the conference reception or cocktail later at the bar!
Thank you everyone for visiting us and joining our events during the 44th Annual ASHI Meeting. The Omixon Team – Efi, Maggi, Ellia, Renata, Nora, Kriszta, Pete, Dan, Gergo and Attila – went on a trip to Baltimore, Maryland, the home of crab cakes, a stunning harbor and lots...
Written by Nina Lauterbach, PhD (Field Application Scientist, Omixon) Animals, and us humans, are daily under attack by viruses and other pathogens. Fortunately, we are equipped with the Major Histocompatibility Complex (MHC) as an efficient and adaptable fighting mechanism to deal with these threatening events. This complex is encoded...
Omixon announce today that Holotype HLA and other Omixon products will be featured among nine posters produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s Lunch Symposium on Thursday 10/4 will focus on the importance...
Global molecular diagnostics company Omixon, headquartered in Budapest, and technology company PIRCHE AG, headquartered in Berlin announce a collaboration to deliver the first integrated epitope determination and matching service that leverages whole gene consensus sequences assembled from NGS data of the HLA region. For the first time, fully characterized...